Cooper, James E <br/><br/>
Bortezomib use in chronic antibody-mediated allograft dysfunction: updates and additional cases.  [electronic resource] 

 -  Clinical transplants  2010 
 - 415-20 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>0890-9016 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Boronic Acids--therapeutic use<br/>Bortezomib<br/>Chronic Disease<br/>Female<br/>Graft Rejection--immunology<br/>Graft Survival--drug effects<br/>HLA Antigens--immunology<br/>Humans<br/>Immunity, Humoral--drug effects<br/>Immunosuppressive Agents--therapeutic use<br/>Isoantibodies--blood<br/>Kidney Transplantation--immunology<br/>Male<br/>Middle Aged<br/>Protease Inhibitors--therapeutic use<br/>Proteasome Endopeptidase Complex--metabolism<br/>Proteasome Inhibitors<br/>Pyrazines--therapeutic use<br/>Time Factors<br/>Treatment Outcome<br/>Young Adult